Opiate Substitution Treatment

"Opiate Substitution Treatment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Medical treatment for opioid dependence using a substitute opiate such as METHADONE or BUPRENORPHINE.

Descriptor ID	D058850
MeSH Number(s)	E02.319.620
Concept/Terms	Opiate Substitution Treatment Opiate Substitution Treatment Opiate Substitution Treatments Substitution Treatment, Opiate Substitution Treatments, Opiate Treatment, Opiate Substitution Treatments, Opiate Substitution Opioid Substitution Treatment Opioid Substitution Treatments Substitution Treatment, Opioid Substitution Treatments, Opioid Treatment, Opioid Substitution Treatments, Opioid Substitution Opioid Substitution Therapy Opioid Substitution Therapies Substitution Therapies, Opioid Substitution Therapy, Opioid Therapies, Opioid Substitution Therapy, Opioid Substitution Opiate Replacement Therapy Opiate Replacement Therapies Replacement Therapies, Opiate Replacement Therapy, Opiate Therapies, Opiate Replacement Therapy, Opiate Replacement Opioid Replacement Therapy Opioid Replacement Therapies Replacement Therapies, Opioid Replacement Therapy, Opioid Therapies, Opioid Replacement Therapy, Opioid Replacement

Below are MeSH descriptors whose meaning is more general than "Opiate Substitution Treatment".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Opiate Substitution Treatment [E02.319.620]

Below are MeSH descriptors whose meaning is more specific than "Opiate Substitution Treatment".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Opiate Substitution Treatment" by people in this website by year, and whether "Opiate Substitution Treatment" was a major or minor topic of these publications.

Bar chart showing 146 publications over 17 distinct years, with a maximum of 21 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2010	1	0	1
2011	2	0	2
2012	6	1	7
2013	3	1	4
2014	5	1	6
2015	9	0	9
2016	6	2	8
2017	6	3	9
2018	6	2	8
2019	5	3	8
2020	3	5	8
2021	1	8	9
2022	0	17	17
2023	0	10	10
2024	14	7	21
2025	12	4	16
2026	3	0	3

Below are the most recent publications written about "Opiate Substitution Treatment" by people in Profiles.

Stopka TJ, Rottapel RE, Ruggiro M, Santelices C, Friedmann PD, Pivovarova E, Evans EA. "So what's gonna happen when I get out of here?" Qualitative barriers and facilitators to MOUD continuity post-release from jail. Drug Alcohol Depend. 2026 Aug 01; 285:113227.

View in: PubMed
Votaw VR, Rosen RL, Peckham AD, London Z, Philpotts LL, Weiss RD, McHugh RK, Streck JM. Investigating the Effects of Buprenorphine Treatment on Depression Symptoms Among Adults with Opioid Use Disorder: A Scoping Review. J Dual Diagn. 2026 Apr; 22(2):158-190.

View in: PubMed
Schoenfeld EM, Soares WE, Girardin AL, Simon C, Strokes N, Lauren N, Santana CS, Beck SA, Westafer LM. "Talk About It!" Shared Decision-Making for Methadone and Buprenorphine Initiation: Development and Preliminary Evaluation of a Conversation Aid via Community-Based Participatory Research. Acad Emerg Med. 2026 03; 33(3):e70256.

View in: PubMed
Pivovarova E, Friedmann PD, Ferguson W, Bovell Ammon BJ, Stopka TJ, Evans EA. Perceived impacts of medications for opioid use disorder implementation on mental health services and substance use counseling in carceral settings: qualitative findings from 13 Massachusetts jails. Addict Sci Clin Pract. 2025 12 22; 21(1):11.

View in: PubMed
Oser CB, Sprunger JG, Hunt T, Holloway J, Chandler RK, Freisthler B, Balvanz P, Henry BF, Glasgow L, Harris DR, Walsh SL, Aldridge AP, Asman K, Blevins D, Booty MD, Fox AD, Springer SA, Kinnard EN, Knott C, LeBaron PA, Levin FR, Marks KR, McGladrey ML, Nunes EV, Oga EA, Smith MR, Smith MS, Staton M, Stevens-Watkins D, Surratt HL, Walters ST, Zarkin GA, Friedmann PD. The impact of the communities that HEAL intervention on the provision of jail-based medication for opioid use disorder & linkage programs at release: Results from a randomized, wait-list controlled trial. J Subst Use Addict Treat. 2026 Feb; 181:209835.

View in: PubMed
Wolkowicz NR, Musket CW, Sofuoglu M, Reilly ED, MacLean RR, Portnoy GA. U.S. Military Veteran Perspectives on Barriers and Facilitators to Medication Treatment for Opioid Use Disorder. Subst Use Misuse. 2026; 61(6):858-870.

View in: PubMed
Rottapel RE, Stopka TJ, Friedmann PD, Hoskinson RA, Englander D, Calhoun N, Senst T, Gudas C, Koutoujian PJ, Farabee D. A protocol for a randomized comparison of extended-release versus sublingual buprenorphine among pre-trial detainees in jail. Addict Sci Clin Pract. 2025 10 27; 20(1):88.

View in: PubMed
Krawczyk N, Scott J, Miller M, Coulter A, Ferguson A, Frank D, Jordan A, Joudrey P, Kimmel SD, Levander XA, Potee R, Roberts KE, Russell D, Simon R, Sue KL, Suen LW, Vincent L, Voyles N, Simon C. Envisioning a Humane and Accessible US Methadone Treatment System: Generating Policy and Practice Recommendations From the Liberate Methadone Movement. Subst Use Addctn J. 2026 04; 47(2):316-325.

View in: PubMed
Ostrowski SJ, Adkins A, Goldfarb D, Kukowski M, Stratton D, Barton DJ, Pizon AF. Transdermal buprenorphine patch-facilitated induction of sublingual buprenorphine in hospitalized patients receiving full agonist opioids: a retrospective cohort study. Clin Toxicol (Phila). 2025 Nov; 63(11):897-905.

View in: PubMed
Friedmann PD, Wilson D, Stopka TJ, Bernson D, Pivovarova E, Ferguson W, Hoskinson RA, Rottapel RE, Bovell-Ammon B, Gaba A, Morgan JR, Senst T, Hayes E, Evans EA. Medications for Opioid Use Disorder in County Jails - Outcomes after Release. N Engl J Med. 2025 Sep 11; 393(10):994-1003.

View in: PubMed

People

Explore

Similar Concepts

Top Journals